Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AIkido Pharma SPEX

Healthcare Biotechnology
AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SPEX)

AIkido Pharma Continues Share Repurchase Program

PR Newswire October 3, 2022

AIkido Provides Update on Use of Machine Learning in Drug Development Program

PR Newswire August 6, 2021

Notice of Allowance Issued for Central Nervous System Peptide Technology

PR Newswire July 27, 2021

AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland

PR Newswire July 16, 2021

AIkido Pharma to Attend the Alzheimer's Association International Conference

PR Newswire July 13, 2021

AIkido Pharma Files Patent Application for the Use of Ketamine to Treat Alzheimer's Disease

PR Newswire June 23, 2021

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

PR Newswire June 4, 2021

AIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of Clinical Oncology ("ASCO") Annual Meeting

PR Newswire May 20, 2021

AIKI Featured as Stock to Watch Ahead of Significant Key Milestones

Newsfile May 19, 2021
View More News ››

Opinion & Analysis (NDAQ:SPEX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SPEX)

Dominari Holdings Inc. (DOMH): Navigating the Fintech Fronti

http://beyondspx.com/2024/08/01/dominari-holdings-inc-domh-navigating-the-fintech-frontier-with-precision/
MikeTester - August 2, 2024

AIKI - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - September 28, 2021

Mark G. Gomez Co-Founder of Canna Ventures, LLC likes $AIKI

On a recent appearance of Investing Today podcast he mentioned a few #Shrooms #Psilocybin plays such as $MNMD $MYCOF $ATAI $LRSV $AIKI...
HampsStockstar - August 1, 2021

RE:RE:RE:Terrible game played by this company

This is silly. $86.2 million invested at $1.60, now trading at a 20% discount.
fnapts - February 25, 2021

RE:RE:Terrible game played by this company

Bought in PM. Wish I saw this a couple days ago, I would have loaded up on those shares that sold near $1.
fnapts - February 24, 2021

RE:Terrible game played by this company

They closed a $86.2 million bought deal at $1.60 (upsized from $10 million) without warrants. Seriously?
fnapts - February 23, 2021
View more Bullboard ››

Xcyte Digital Corp.

Xcyte Digital Corp.

Xcyte Digital is a virtual event company focused on simplifying the event hosting industry and expanding event hosting ...
View More »